PURPLE BIOTECH LTD-ADR (PPBT)

US74638P1093 - ADR

4.815  -1.75 (-26.71%)

After market: 4.89 +0.07 (+1.56%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

PURPLE BIOTECH LTD-ADR

NASDAQ:PPBT (12/4/2024, 8:04:59 PM)

After market: 4.89 +0.07 (+1.56%)

4.815

-1.75 (-26.71%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-57.87%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap163.27M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

PPBT Daily chart

Company Profile

Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Company Info

PURPLE BIOTECH LTD-ADR

4 Oppenheimer St., Science Park

Rehovot 7670104

P: 97239333121

CEO: Gil Efron

Employees: 20

Website: https://purple-biotech.com/

PPBT News

ChartMill News Imagea day ago - ChartmillThe trading volume of these stocks is deviating from the norm in today's session.

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

ChartMill News Imagea day ago - ChartmillThere are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.

Let's have a look at the gap up and gap down stocks in today's session.

News Image2 days ago - Purple Biotech Ltd. Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
News Image2 days ago - Purple Biotech Ltd. Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares

REHOVOT, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company...

News Image3 days ago - Purple Biotech Ltd. Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer
News Image20 days ago - Purple Biotech Ltd. Purple Biotech Reports Third Quarter 2024 Financial Results

Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024 New CM24 biomarkers data presented during the third quarter of 2024...

PPBT Twits

Here you can normally see the latest stock twits on PPBT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example